Home Health Agency Valuation & Sale Process
Thinking about selling your home health agency? The first step is understanding what buyers will actually pay for: adjusted EBITDA they can trust, referral relationships that hold, and clean compliance. A valuation tells you your number today, and which levers would raise it.
Free valuation calculator What moves your number Jump to FAQs
No upfront fee. No obligation. Success-based, confidentiality-first advisory.
Why is home health valuation different?
Home health valuation is different because so much of the value sits in things a buyer has to verify: your adjusted EBITDA, the durability of your referral sources, and a compliance record that survives diligence. Two agencies with the same revenue can be worth very different amounts once a buyer tests how dependable those three are.
As of June 2026, most home health agencies trade in the 3.5x to 7.0x EBITDA range, with premium platforms higher and small, owner-dependent agencies lower. The CMS CY2026 final rule landed at a net 1.3 percent cut, milder than proposed, and buyers tightened their EBITDA add-backs from roughly 20 percent to 12 to 15 percent. These are ranges, not promises, and clean documentation is now what defends your number.
Adjusted EBITDA
Buyers pay a multiple of normalized earnings, and in 2026 they accept fewer add-backs. Defensible, well-documented EBITDA holds your multiple.
Referral stability
Diversified, durable referral relationships lower the risk that revenue moves after a sale. Concentration in one source is discounted.
Compliance
A clean survey history and tidy documentation remove the uncertainty buyers price in, and keep value from leaking during diligence.
What do buyers look for in a home health agency?
Buyers look for an agency that runs without the owner in the middle of every decision, with dependable referrals and clean books. The most active acquirers are private-equity-backed home-based-care platforms, regional strategics, and larger agencies expanding their footprint.
- Defensible adjusted EBITDA — normalized earnings with add-backs that hold up under 2026 diligence standards.
- Diversified referral sources — no single hospital, physician group, or facility driving too much of admissions.
- A clean compliance and survey history — minimal deficiencies and complete, organized documentation.
- Stable clinical staffing — retained nurses and therapists, with manageable turnover and contract labor.
- A favorable payer profile — a payer and case mix the buyer can underwrite with confidence.
- Low owner dependence — a management layer that runs day-to-day operations.
What drives a home health agency's valuation multiple?
The multiple a buyer applies reflects how transferable and predictable your earnings are. These are the levers that move it most, and most can be improved in the 6 to 12 months before you go to market.
| Value driver | Effect on multiple | Why buyers care |
|---|---|---|
| Diversified, durable referral sources | Raises | Admissions hold after the owner exits |
| Clean compliance and survey history | Raises | Less risk surfaces in diligence |
| Defensible adjusted EBITDA and staffing | Raises | Earnings and care capacity are dependable |
| Referral concentration in one source | Lowers | Revenue may move if that source changes |
| Owner dependence and thin documentation | Lowers | Harder to transfer; add-backs get rejected |
Directional effect on home health multiples, as of mid-2026. Sources: FOCUS Investment Banking home health and hospice EBITDA multiples, 2026; CMS CY2026 Home Health Final Rule. Most levers can be improved before going to market.
How does the sale process work?
A confidential process typically runs 6 to 9 months from valuation to close, and most owners benefit from starting 6 to 18 months ahead to raise the drivers above. The arc is straightforward.
Baseline value + prep plan
We rebuild adjusted EBITDA, review referrals and compliance, and identify the changes that will lift your multiple.
Confidential marketing
We approach qualified buyers behind NDAs, protecting your staff, referral sources, and patients while creating competition.
Diligence + close
We manage clinical and financial diligence, negotiate terms, and guide the transition so value holds through to closing.
What should home health owners know about the market?
The 2026 reimbursement picture turned out milder than feared, and home-based-care M&A has reset rather than retreated. Buyers remain active but more disciplined, which means a prepared agency with clean documentation and diversified referrals is in a strong position, while an unprepared one leaves value on the table.
typical home health EBITDA range (premium platforms higher)
net CMS CY2026 payment change, milder than the proposed cut
EBITDA add-backs buyers now accept, down from about 20%
Sources: CMS CY2026 Home Health Final Rule; FOCUS Investment Banking, 2026; Mertz Taggart home-based-care M&A reporting, 2026.
See where your home health agency stands
Start with a confidential estimate, then test the number against live buyer demand. A valuation is a planning tool. It commits you to nothing.
No upfront fee. No obligation.
Resources to go deeper
Home health valuation & selling FAQs
How is a home health agency valued?
A home health agency is valued by normalizing earnings into adjusted EBITDA, applying a market multiple for your size and profile, and adjusting for the risks a buyer tests in diligence, chiefly referral concentration, compliance history, and staffing stability. As of June 2026 most agencies trade in the 3.5x to 7.0x EBITDA range.
What is the difference between a home health appraisal and a valuation?
An appraisal is typically a formal, standards-based opinion of value for a specific legal or financial purpose, while a market valuation estimates what buyers would actually pay today given live demand. For a sale decision, a market valuation tested against active buyers is usually the more useful number.
How do I sell my home health agency without employees finding out?
A confidential process protects you. Buyers sign NDAs before any identifying details are shared, sensitive information is released in stages, and staff and referral sources are only informed at the point you choose, typically near closing. Confidentiality-first marketing is standard practice for an agency sale.
What documents will buyers request?
Expect requests for financial statements and tax returns, a payer and referral-source breakdown, census and case-mix data, compliance and survey history, staffing and turnover detail, and key contracts. Organized, complete documentation is one of the most reliable ways to protect your multiple.
What should I do first if I want to sell?
Start with a valuation, even if you are 6 to 18 months out. It establishes your baseline, shows which drivers are costing you multiple, and gives you time to fix them. A valuation is confidential and carries no obligation.
Will a valuation obligate me to sell?
No. A valuation is confidential and carries no obligation. It is a planning tool that tells you what your agency is worth today and what would make it worth more, so any future decision is yours to make on your own timeline.
Find out what your home health agency is worth
Vallexa Advisors is a healthcare-only M&A firm with deep roots in home health. We help owners understand value, prepare intelligently, and run a confidential sale process that attracts qualified buyers.
No upfront fee. No obligation. 100% success-based.
Educational only. Not legal, financial, or tax advice. Home health M&A outcomes depend on specific facts, payer mix, referral relationships, market conditions, and regulatory context. Speak with qualified counsel before acting on anything on this page.